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Medical Campus, Aurora, ColoradoABSTRACT Recently, we characterized the functional properties of a mutant skeletal muscle L-type Ca2þ channel (CaV1.1
R174W) linked to the pharmacogenetic disorder malignant hyperthermia. Although the R174W mutation neutralizes the inner-
most basic amino acid in the voltage-sensing S4 helix of the first conserved membrane repeat of CaV1.1, the ability of the mutant
channel to engage excitation-contraction coupling was largely unaffected by the introduction of the bulky tryptophan residue. In
stark contrast, the mutation ablated the ability of CaV1.1 to produce L-type current under our standard recording conditions. In
this study, we have investigated the mechanism of channel dysfunction more extensively. We found that CaV1.1 R174W will
open and conduct Ca2þ in response to strong or prolonged depolarizations in the presence of the 1,4-dihydropyridine receptor
agonist5Bay K 8644. From these results, we have concluded that the R174Wmutation impedes entry into both mode 1(low Po)
and mode 2 (high Po) gating states and that these gating impairments can be partially overcome by maneuvers that promote
entry into mode 2.INTRODUCTIONThe principal a1S subunit (CaV1.1) of the skeletal muscle
L-type Ca2þ channel is a single polypeptide composed of
four conserved domains (RI–RIV), each consisting of
six transmembrane segments (S1–S6); the amino- and
carboxyl-termini and the linkers joining the repeats are all
cytoplasmic (1). Like other CaV family channels, the pri-
mary voltage-sensing structures for CaV1.1 are the S4 heli-
ces of each transmembrane repeat (1,2). It has been
established that regularly spaced basic residues within a
given S4 helix translocate with respect to the electrical field
across the plasma membrane in response to depolarization
(3). In the unique case of CaV1.1, the movement of the S4
helices is directly responsible for triggering voltage-induced
Ca2þ release from the sarcoplasmic reticulum (SR) (i.e.,
skeletal-type excitation-contraction (EC) coupling (4–7)).
In addition, the movement of the S4 helices causes further
conformational rearrangements in the channel, which are
coupled to opening of the pore allowing Ca2þ flux into the
myoplasm (6). For CaV1.1, movement of the RI S4
voltage-sensing helix has been identified as a likely rate
determining step in channel activation (8–10).
Like other L-type channels, CaV1.1 has three broadly
defined gating modes (11). Mode 0 is characterized by
null single channel sweeps and is indicative of the closed
state of the channel, mode 1 has very brief (~1 ms), infre-
quent openings, and mode 2 displays openings with longer
dwell times, which are induced by strong depolarization
and/or by exposure to 1,4-dihydropyridine agonists such
as ()Bay K 8644 (11–14). On the whole-cell level, entrySubmitted February 14, 2013, and accepted for publicationMarch 25, 2013.
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0006-3495/13/05/1917/6 $2.00into mode 2 is manifested by the enhanced amplitude, and
decelerated decay, of tail currents upon repolarization.
We (15) have recently described the impact of a malig-
nant hyperthermia-linked mutation in CaV1.1 (R174W;
see (16)) on the functional properties of the channel.
Although this mutation occurs at the innermost basic residue
of the RI S4 helix (1–3), the intramembrane charge move-
ment generated by depolarization was very similar to that
of wild-type CaV1.1, as was the ability of the R174W
mutant to engage EC coupling. In stark contrast, the
R174W mutation virtually ablated the ability of CaV1.1 to
produce L-type Ca2þ current during 200 ms depolarizations.
These earlier findings have raised the question of whether
this disease-causing mutation renders the channel
completely incapable of opening. Here, we have addressed
the question by investigating the gating behavior of
CaV1.1 R174W in response to manipulations known to
cause wild-type CaV1.1 channels to enter into a gating
mode of higher open probability. We have found that
CaV1.1 R174W will produce inward current under these
conditions, although the entry into mode 2 requires stronger
depolarization and occurs much more slowly.MATERIALS AND METHODS
Myotube culture and cDNA expression
All procedures involving mice were approved by the University of Colorado
Denver-Anschutz Medical Campus Institutional Animal Care and Use
Committee. Primary cultures of dysgenic (mdg/mdg) myotubes were pre-
pared as described previously (17). Cultures were grown for 6–7 days in
a humidified 37C incubator with 5% CO2 in Dulbecco’s modified Eagle
medium (DMEM; #15-017-CM, Mediatech, Herndon, VA), supplemented
with 10% fetal bovine serum/10% horse serum (Hyclone Laboratories,
Logan, UT). This medium was then replaced with differentiation medium
(DMEM supplemented with 2% horse serum). 2–4 days following the shifthttp://dx.doi.org/10.1016/j.bpj.2013.03.035
w/ Bay K 8644A Bcontrol
YFP-CaV1.1
1918 Bannister and Beamto differentiation medium, single nuclei were microinjected with 200 ng/ml
plasmid cDNA encoding either YFP-CaV1.1 (18) or YFP-CaV1.1 R174W
(15). Fluorescent myotubes were used in experiments 2 days following
microinjection.D
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FIGURE 1 Potentiation of wild-type CaV1.1 tail currents by Bay K 8644.
Representative currents evoked by the illustrated voltage protocol are
shown for dysgenic myotubes expressing YFP-CaV1.1 in the absence (A)Measurement of Ca2D currents
All experiments were performed at room temperature (~25C). Pipettes
were fabricated from borosilicate glass and had resistances of ~2.0 MU
when filled with internal solution, which consisted of (mM): 140 Cs-aspar-
tate, 10 Cs2-EGTA, 5 MgCl2, and 10 HEPES, pH 7.4 with CsOH. The
standard external solution contained (mM): 145 tetraethylammonium
(TEA)-Cl, 10 CaCl2, 0.002 tetrodotoxin, 0.01 N-Benzyl-P-toluensulfona-
mide (#S949760, Sigma-Aldrich, St. Louis, MO), and 10 HEPES, pH 7.4
with TEA-OH. In some experiments, 5Bay K 8644 was included in the
external solution. For the generation of current-voltage relationships, linear
capacitative and leakage currents were determined by averaging the cur-
rents elicited by 11, 30 mV hyperpolarizing pulses from the holding poten-
tial of 80 mV. Test currents were corrected for linear components of leak
and capacitive current by digital scaling and subtraction of this average con-
trol current. In all other experiments,P/4 subtraction was employed. Elec-
tronic compensation was used to reduce the effective series resistance
(usually to<1 MU) and the time constant for charging the linear cell capac-
itance (usually to<0.5 ms). L-type currents were filtered at 2 kHz and digi-
tized at 5–10 kHz. In some cases, a 1 s prepulse to 20 mV followed by a
50 ms repolarization to 50 mV was administered before the test pulse
(prepulse protocol; see (19)) to inactivate Naþ and T-type Ca2þ channels.
Cell capacitance was determined by integration of a transient from 80
to 70 mV using Clampex 8.0 (Molecular Devices, Sunnyvale, CA) and
was used to normalize current amplitudes (pA/pF).and the presence (B) of 5Bay K 8644 (10 mM). The currents elicited by
depolarization to þ40 or þ90 mV are indicated in green and red, respec-
tively, with the tail currents upon repolarization to 50 mV shown on an
expanded time base in the insets in A and B. (C) Summary of amplitudes
of YFP-CaV1.1 tail currents recorded in the absence (A; n ¼ 18) and pres-
ence (>; n ¼ 10) of 5Bay K 8644. (D) Summary of half-times of YFP-
CaV1.1 tail current decay recorded in the absence (left panel) and presencePharmacology
Racemic Bay K 8644 (kindly supplied by Dr. A. Scriabine, Miles Labora-
tories, New Haven, CT) was stored at 4C as a 20 mM stock in 50% EtOH,
diluted to 10 mM just before use, and used in the dark.(right panel) of 5Bay K 8644. Asterisks indicate significant differences
(* denotes p< 0.05, ** denotes p< 0.005, *** denotes p< 0.001, unpaired
t-test in C and ANOVA for both panels in D). Bars represent mean 5 SE
throughout.Analysis
Figures were made using the software program SigmaPlot (version 11.0,
SSPS, Chicago, IL). All data are presented as mean5 SE. Statistical com-
parisons were made by unpaired, two-tailed t-test or by one-way ANOVA
(as appropriate), with p < 0.05 considered significant.RESULTS
Tail currents of wild-type CaV1.1 channels are
potentiated by Bay K 8644
As has been extensively documented, wild-type YFP-
CaV1.1 produced robust, L-type currents during 200 ms
depolarizations, and the subsequent tail currents increased
in amplitude as a function of the prior test pulse (Fig. 1, A
and C; cf. Fig. 3 C of (20)). The decay rate of the tail cur-
rents was similar upon repolarization to 50 mV following
steps to either þ20 orþ40 mV (t1/2-deact ¼ 1.45 0.2 ms vs.
1.7 5 0.2 ms, respectively; p > 0.05; Fig. 1 D), demon-
strating that the wild-type channel resides in a similar gating
state (i.e., predominantly mode 1) in this range of potentials.
As the prior test depolarization was increased from þ40
to þ90 mV, there was a prominent slowing of tail currentBiophysical Journal 104(9) 1917–1922decay (to t1/2-deact ¼ 2.5 5 0.2 ms; p < 0.05, ANOVA),
which is indicative of entry of the channels into a longer
duration open state (i.e., mode 2). Application of the 1,4-
dihydropyridine agonist5Bay K 8644 (10 mM) to dysgenic
myotubes expressing YFP-CaV1.1 further increased tail cur-
rent amplitude and caused a substantial slowing of the tail
current (see Fig. 1 B). Specifically, tail current density
upon repolarization from þ90 to 50 mV increased from
50.1 5 8.6 pA/pF (n ¼ 18) to 106.5 5 17.4 pA/pF
(n ¼ 10; p < 0.005, unpaired t-test; Fig. 1 C) and the
half-time of tail current decay increased from 2.5 5
0.2 ms to 28.7 5 8.8 ms (p < 0.001, unpaired t-test;
Fig. 1 D) in the presence of5Bay K 8644.Potentiated CaV1.1 R174W conducts inward Ca
2D
current
As we demonstrated previously (15), YFP-CaV1.1 R174W
was incapable of producing inward current during 200 ms
Impaired Gating of CaV1.1 R174W 1919step depolarizations and the inward currents generated by
repolarization to 50 mV were small and did not show
slowed decay as the test depolarization was increased
fromþ40 toþ90 mV (Fig. 2 A). Indeed, the inward and out-
ward transient currents at the onset and offset of the depola-
rizing step roughly mirrored one another, consistent with the
idea that both were generated by membrane-bound charge
movement and that YFP-CaV1.1 R174W produces neither
mode 1 nor mode 2 openings in response to 200 ms depolar-
izations. Fig. 2 B shows a recording from another dysgenic
myotube expressing YFP-CaV1.1 R174W in the presence
of 5Bay K 8644. Similar to the recordings made in the
absence of 5Bay K 8644, very little inward step current
was evoked during 200 ms depolarizations. However, large,
slowly decaying tail currents were evident upon repolariza-
tion from test potentials > þ50 mV (Fig. 2, B and C). In
particular, the average amplitude of tail currents elicited
by repolarization from þ90 to 50 mV was augmentedw/ Bay K 8644A B
D
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FIGURE 2 Potentiated CaV1.1 R174W conducts inward Ca
2þ tail cur-
rent. Representative currents evoked by the illustrated voltage protocol
are shown for dysgenic myotubes expressing YFP-Cav1.1 R174W in the
absence (A) and the presence (B) of5Bay K 8644 (10 mM). The currents
elicited by depolarization toþ40 orþ90 mVare indicated in green and red,
respectively, with the tail currents upon repolarization to50 mV shown on
an expanded time base in the insets in A and B. (C) Summary of amplitudes
of YFP-CaV1.1 R174W tail currents recorded in the absence (C; n ¼ 9)
and presence (B; n ¼ 10) of 5Bay K 8644. Also shown in panel C are
the corresponding control data for naive dysgenic myotubes in the presence
of5Bay K 8644 (C; n ¼ 6). (D) Summary of half-times of YFP-CaV1.1
R174W tail current decay recorded in the absence (black bars) and presence
(white bars) of 5Bay K 8644. Asterisks indicate significant differences
(* denotes p < 0.05; ** denotes p < 0.005; *** denotes p < 0.001,
ANOVA in both C and D).nearly fourfold by exposure to 5Bay K 8644 relative to
that of untreated dysgenic myotubes expressing YFP-
CaV1.1 R174W (31.8 5 6.6 pA/pF; n ¼ 9 vs. 7.7 5
1.0 pA/pF; n ¼ 5; p < 0.005, unpaired t-test). Likewise,
tail current deactivation recorded in the presence of 5Bay
K 8644 was substantially slowed compared to the deactiva-
tion of tail currents recorded from untreated cells expressing
YFP-CaV1.1 R174W (t1/2-deact ¼1.9 5 0.2 ms vs. 5.0 5
0.5 ms; p < 0.001, unpaired t-test; Fig. 1 D). Importantly,
the tail current amplitude in 5Bay K 8644-treated, YFP-
CaV1.1 R174W-expressing dysgenic myotubes was consid-
erably greater than in naive,5Bay K 8644-treated dysgenic
myotubes (Fig. 1, C and D), indicating that the augmented
tail currents of the former did not arise from the endogenous
L-type current of dysgenic myotubes (Idys; see (21)).
A fraction of the repolarization current observed in the
presence of 5Bay K 8644 most certainly was attributable
to membrane-bound gating charge movement (see above).
However, based on the reasoning described below, this
component was likely to have been insignificant. Specif-
ically, in the absence of 5Bay K 8644, Qon and Qoff were
similar to one another, both for YFP-CaV1.1 and YFP-
CaV1.1 R174W (see Fig. 1 of (15)). Also in the absence
of 5Bay K 8644, Qon was similar for YFP-CaV1.1 and
YFP-CaV1.1 R174W (15). Furthermore, Qon for R174W
was little affected by 5Bay K 8644 (6.3 5 0.7 nC/mF,
n ¼ 7 vs. 5.8 5 0.8 nC/mF, n ¼ 10; p < 0.05, unpaired
t-test). Thus, the contribution of Qoff (~6 nC/mF) to the inte-
grated current produced by repolarization from þ90 to 50
should have been minor for both YFP-CaV1.1 and YFP-
CaV1.1 R174W (3464.5 5 1437.0 nC/mF and 249.5 5
69.1 nC/mF, respectively). Taken together, the results of
Figs. 1 and 2 show that wild-type CaV1.1 channels exhibit
both mode 1 and mode 2 gating during 200 ms step depolar-
ization in the absence of Bay K 8644 (Fig. 1), whereas
CaV1.1 R174W channels are incapable of these transitions
without agonist (Fig. 2).Strong depolarization in the presence of 5BayK
8644 causes CaV1.1 R174W to gate into mode 2
openings
Large, slowly decaying tail currents for YFP-CaV1.1 R174W
were apparent following depolarizing test potentials greater
than about þ50 mV (see Fig. 2, B–D), suggesting that the
combined application of agonist and strong depolarization
were driving the channel into mode 2 gating. To test this
idea, we used the voltage protocols illustrated at the top of
Fig. 3 in which we compared the current at þ60 mV
recorded following 200 ms depolarizations to either þ60
or þ90 mV in the presence of 5Bay K 8644. When the
membrane potential was maintained at þ60 mV following
the initial 200 ms depolarization in this representative exper-
iment, there was a subtle hint of inward Ca2þ current (Fig. 3,
black trace). However, substantial inward Ca2þ current wasBiophysical Journal 104(9) 1917–1922
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FIGURE 3 After strong depolarization in the presence of5Bay K 8644,
CaV1.1 R174W produces long-lasting inward Ca
2þ current. Currents from a
YFP-CaV1.1 R174W-expressing dysgenic myotubes were elicited by an
initial 200 ms step depolarization to either þ60 mV (black trace)
or þ90 mV (red trace), followed by 100 ms at þ60 mV, before final repo-
larization to 20 mV (illustrated at top). Note the substantial, sustained in-
ward current recorded at þ60 mV following the step to þ90 mV and the
enhanced tail current upon repolarization to 20 mV. Similar behavior
was observed in a total of six cells (see text).
FIGURE 4 CaV1.1 R174W opens in response to long depolarizations in
the presence of 5Bay K 8644. Recordings of Ca2þ currents elicited by
2 s depolarizations from 50 mV to the indicated test potentials are shown
1920 Bannister and Beamapparent upon repolarization to þ60 mV following the
200 ms depolarization to þ90 mV (4.9 5 1.2 pA/pF vs.
0.25 0.3 pA/pF, n ¼ 6, p < 0.005; Fig. 3, red trace), indi-
cating entry of the channel into a higher Po state.for dysgenic myotubes expressing either YFP-CaV1.1 (A) or YFP-CaV1.1
R174W (B).
CaV1.1 R174W channels open during long
depolarizations in the presence of 5BayK 8644
In addition to strong depolarizations, long depolarizations
can also drive L-type channels into mode 2 gating (14).
As shown in Fig. 3, a hint of inward current began to
develop near the end of 300 ms long depolarizations
to þ60 mV. In light of this observation, we investigated
whether significant current via YFP-CaV1.1 R174W could
be evoked by 2 s long depolarizations in the presence
of5Bay K 8644. To this end, we observed inward currents
of variable amplitude in five dysgenic myotubes expressing
YFP-CaV1.1R174W (0.665 0.41 pA/pF); Fig. 4 A shows
a family of currents recorded from one of these cells. In this
particular myotube, the current density at the end of the 2 s
depolarization from 50 to þ50 mV was 2.2 pA/pF. The
activation of the current in dysgenic myotubes expressing
YFP-CaV1.1 R174W was quite slow in comparison to
dysgenic myotubes expressing YFP-CaV1.1 (Fig. 4 B;
t1/2-act ¼ 9628 5 144 ms, n ¼ 4 vs. 53.2 5 21.9 ms,
n ¼ 8, respectively; p < 0.005). In control experiments,
only outward current was observed in naive dysgenic myo-
tubes (n ¼ 4; data not shown).DISCUSSION
In agreement with many previous studies, wild-type CaV1.1
(Fig. 1 A) displayed slowly activating inward Ca2þ currentBiophysical Journal 104(9) 1917–1922during 200 ms depolarizations, which represent predomi-
nantly mode 1 gating for test potentials up to
around þ40 mV, as indicated by rapid deactivation of the
tail currents upon repolarization. Additionally, exposure to
Bay K 8644 or depolarizations to potentials greater than
about þ40 mV caused mode 2 gating of wild-type
CaV1.1, as indicated by increased tail current amplitude
and slowed tail current decay (Fig. 1, B–D). By contrast,
200 ms depolarizations over the same voltage range failed
to cause either mode 1 or mode 2 gating of CaV1.1
R174W (Fig. 2 A). Even in the presence of the 1,4-dihydro-
pyridine agonist 5Bay K 8644, little or no inward Ca2þ
current via CaV1.1 R174Woccurred during 200 ms depolar-
izations, although test potentials > þ40 mV caused mode 2
gating, as indicated by slowly deactivating, inward, Ca2þ
current upon repolarization (Fig. 2, B–D, Fig. 3). However,
the ability of CaV1.1 R174W to transition from mode 0 to
mode 2 was impaired even in the presence of Bay K 8644,
such that its entry into mode 2 required stronger depolariza-
tion (compare Figs. 1 C and 2 C). Despite the case that entry
into mode 2 was strongly impaired for CaV1.1 R174W, there
was sufficient entry into mode 2 in the presence of5Bay K
8644 that very slowly activating inward currents were
observed during prolonged (2 s) depolarizations (Fig. 4).
Previously, we showed that although the R174W
mutation suppressed inward current during 200 ms
Impaired Gating of CaV1.1 R174W 1921depolarizations, it had no significant effect on the voltage
dependence of either membrane-bound charge movement
or EC coupling Ca2þ release (15). The observation that
the mutation had no effect on charge movement is consistent
with our earlier work (10), which suggested that IS4 moves
too slowly to produce a measureable charge movement upon
depolarization. In regard to EC coupling, previous work had
shown that voltage-gated Ca2þ release from the SR occurs
for weak depolarization, and at a much faster rate, than acti-
vation of L-type current via CaV1.1 (6). Thus, it seems
reasonable that the R174W mutation impairs mode 1 and
mode 2 openings of CaV1.1 without affecting EC coupling.
A number of publications (11–14,22) have described
L-type Ca2þ channels as having three gating modes:
mode 0 (deeply closed), mode 1 (brief openings), and
mode 2 (long openings). Additionally, it has been proposed
that there is a reversible transition between mode 0 and
mode 1, between mode 1 and mode 2, and also between
mode 0 and mode 2 (see (12 and 14), for detailed descrip-
tions). Fig. 5 adapts this model to describe the transitions
of CaV1.1 between modes 0, 1, and 2, the relationship of
these gating modes to EC coupling, and the effects on inter-
modal transition caused by the R174W mutation and5Bay
K 8644. In particular, depolarizations that are subthreshold
for activation of L-type current can nonetheless cause the
rapid movement of sufficient charge (Q) to engage EC
coupling within milliseconds (6). Further depolarization
(% ~40 mV) cause the slow movement of an additional,
lesser charge (q), which causes the channel to enter predom-
inantly mode 1, as indicated by the rapid decay of tail cur-
rents (Fig. 1). Because the R174W mutation ablates Ca2þ
current during 200 ms depolarizations without affecting
the voltage dependence of EC coupling, we propose that
the mutation destabilizes mode 1. If mode 2 is predomi-
nantly entered from mode 1, then destabilization of
mode 1 would account both for the absence of inward cur-FIGURE 5 Model for CaV1.1 R174W dysfunction. Mode 0 represents
closed states of CaV1.1. Upon sufficient depolarization, the voltage sensors
of both wild-type CaV1.1 and CaV1.1 R174W translocate within the mem-
brane field producing the movement of charge (Q) and engage EC coupling,
although the channel remains in mode 0. Stronger depolarization of suffi-
cient duration causes the slow movement of additional charge (q) and entry
into mode 1, in which the pore opens with low Po. Our present work indi-
cates that the malignant hyperthermia-linked R174W mutation impairs the
transitions necessary for the channel to enter mode 1. However, strong or
prolonged depolarization in the presence of 5Bay K 8644 sufficiently
accelerates the transition (big arrow) into higher Po mode 2 to overcome
the gating impediment caused by the R174W mutation.rent during 200 ms depolarizations and the absence of a
slowly decaying, Ca2þ tail current, even after depolarization
to þ90 mV, which causes the wild-type channel to enter
mode 2. That is, the very brief sojourns in mode 1 would
result in a negligible probability of entry into mode 2, the
prerequisite for slowly decaying tail current. However, the
combined actions of 5Bay K 8644 and strong/prolonged
depolarization appeared able to overcome such brief spells
in mode 1 by accelerating the transition from mode 1
to mode 2. As stated earlier, it has been proposed that
mode 2 can also be entered directly from mode 0, although
a rigorous experimental test of this proposition is difficult.
However, if a significant fraction of entries into mode 2
occurred from mode 0, we would have to conclude that
the R174W mutation is important for this transition as
well. Independent of the precise mechanism, IS4 appears
to be an important structural element for entry into both
modes 1 and 2.
Based on the crystal structures of the bacterial Naþ chan-
nel NaVAb in the closed state (23) and an insect-based
KV1.2/KV2.1 chimeric channel in the open state (24),
R174 in the closed state of CaV1.1 is positioned below the
highly conserved Phe gap phenylalanine in the adjacent
S2 helix and must pass this aromatic residue for the channel
to open (25). Our data are consistent with the idea that the
introduction of a bulky tryptophan at position 174 strongly
impedes movement of the repeat IS4 through the Phe gap,
and thus stabilizes CaV1.1 in mode 0. Previously, we
observed that a ryanodine-insensitive, SR Ca2þ leak in
resting myotubes is increased in cells expressing CaV1.1
R174W compared to those expressing wild-type CaV1.1,
which agrees with the idea that the resting conformation
of CaV1.1 R174W differs from that of wild-type. Thus,
both these earlier results and the results reported here are
consistent with the idea that the R174W mutation produces
a closed conformation of CaV1.1 that differs structurally and
functionally from wild-type.
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